Care Bare Rx vs Oak Longevity: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Visit Oak Longevity - our pick of these two →or find your match

Oak Longevity beats Care Bare Rx overall, scoring 7.5/10 vs 7.4/10. Published pricing is not a like-for-like monthly comparison: Care Bare Rx is from $199/mo; Oak Longevity is from $119/mo. Choose Care Bare Rx for users who prefer oral glp-1 pills and want a simple, no-appo. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound.

A side-by-side look at Care Bare Rx and Oak Longevity to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Care Bare Rx

#26 of 54

7.4/10

Simple GLP-1 provider offering oral pill options with a streamlined no-appointment-needed process.

Visit Care Bare Rx

Higher Rated

Oak Longevity

#21 of 54

7.5/10

Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing, patients pay each month manually rather than auto-renew.

Visit Oak Longevity

Feature	Care Bare Rx	Oak Longevity
Why each one	Both oral pill and injectable GLP-1 options at the same flat $199/mo rate, backed by named physician leadership.	The no-subscription billing model, patients are not auto-charged each month and renew manually. Combined with the broadest medication mix (compounded GLP-1s + oral Wegovy + brand-name + longevity peptides), Oak occupies a unique position as a 'menu' platform vs. the typical single-product flow.
Our Score	7.4/10	7.5/10
Headline Price	from $199/mo	from $119/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who prefer oral GLP-1 pills and want a simple, no-appointment process	Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin)
Watch out for	Founding date, headquarters, and pharmacy partners are not published. Ask which pharmacy fills your prescription before you order.	Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare lists Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and LillyDirect has Zepbound from $299. Use Oak for its compounded tiers and buy brand-name direct
Ranking	#26	#21
Get started	Visit Care Bare Rx	Visit Oak Longevity

Pros & Cons Compared

Care Bare Rx

Pros

+Both oral pill AND injectable GLP-1 options at the same flat $199/mo rate, flexibility to switch formats
+Named physician leadership (Dr. Ana Lisa Carr MD, Dr. Kelly Tenbrink MD) adds accountability
+Same price at every dose with no hidden fees, simple, transparent billing
+Free shipping included on all orders

Cons

−Founding date, headquarters, and pharmacy partners are not published. Ask which pharmacy fills your prescription before you order.
−Independent reviews are still very limited, so satisfaction and reliability are hard to verify. The named physician leadership is the main trust signal to weigh.
−Cash-pay only: no insurance accepted, and HSA/FSA eligibility isn't disclosed. Budget the $199/mo as a full out-of-pocket cost.

Oak Longevity

Pros

+$119/mo for compounded semaglutide is among the lowest published entries in our provider table
+No-subscription model, patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
+Compounded tirzepatide at $185/mo is competitively priced for a GLP-1+GIP dual agonist
+Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
+Money-back guarantee if not approved by physician, useful safety net for borderline-eligibility patients
+Free shipping and free health coaching included in every program

Cons

−Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare lists Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and LillyDirect has Zepbound from $299. Use Oak for its compounded tiers and buy brand-name direct
−No published lab panels and no specialty (obesity medicine) physicians disclosed, clinical oversight is lighter than lab-driven platforms
−The 'up to 50% cheaper than competitors' marketing claim is unverified and inconsistent, judge Oak on its posted prices, which are genuinely low, not on the slogan
−The longevity add-ons (NAD+, Sermorelin, Tesamorelin) have limited clinical evidence for weight loss specifically, if weight loss is the goal, the GLP-1 alone does the work and the stack is optional
−Newer brand without disclosed company history, founding date, or executive team on landing pages
−Three-month plans are billed upfront, start on the 1-month plan if you're testing the platform, then bundle once it fits

Our Verdict

Oak Longevity edges out Care Bare Rx with a score of 7.5/10 vs 7.4/10. Published pricing is not a like-for-like monthly comparison: Care Bare Rx is from $199/mo; Oak Longevity is from $119/mo. Choose Care Bare Rx if you want: users who prefer oral glp-1 pills and want a simple, no-appointment process. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin).